This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
9 Meters Biopharma 미래 성장
Future 기준 확인 2/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for 9 Meters Biopharma.
주요 정보
41.4%
수익 성장률
39.9%
EPS 성장률
Pharmaceuticals 수익 성장 | 19.6% |
매출 성장률 | 56.6% |
향후 자기자본 수익률 | n/a |
애널리스트 커버리지 | Low |
마지막 업데이트 | 30 May 2023 |
최근 미래 성장 업데이트
Recent updates
수익 및 매출 성장 예측
날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
---|---|---|---|---|---|
12/31/2025 | N/A | -43 | N/A | N/A | 2 |
12/31/2024 | N/A | -41 | N/A | N/A | 3 |
12/31/2023 | 3 | -43 | N/A | N/A | 4 |
3/31/2023 | N/A | -46 | -37 | -37 | N/A |
12/31/2022 | N/A | -44 | -37 | -37 | N/A |
9/30/2022 | N/A | -41 | -35 | -35 | N/A |
6/30/2022 | N/A | -46 | -36 | -34 | N/A |
3/31/2022 | N/A | -43 | -36 | -33 | N/A |
12/31/2021 | N/A | -37 | -32 | -29 | N/A |
9/30/2021 | N/A | -32 | -30 | -28 | N/A |
6/30/2021 | N/A | -27 | -24 | -24 | N/A |
3/31/2021 | N/A | -63 | -26 | -23 | N/A |
12/31/2020 | N/A | -61 | -23 | -19 | N/A |
9/30/2020 | N/A | -65 | -19 | -16 | N/A |
6/30/2020 | N/A | -66 | -19 | -16 | N/A |
3/31/2020 | N/A | -26 | -16 | -16 | N/A |
12/31/2019 | N/A | -27 | -18 | -18 | N/A |
9/30/2019 | N/A | -22 | -17 | -17 | N/A |
6/30/2019 | N/A | -14 | -17 | -17 | N/A |
3/31/2019 | N/A | -14 | -12 | -12 | N/A |
12/31/2018 | N/A | -24 | -15 | -15 | N/A |
9/30/2018 | N/A | -22 | -15 | -15 | N/A |
6/30/2018 | N/A | -24 | -12 | -12 | N/A |
3/31/2018 | N/A | -23 | -11 | -11 | N/A |
12/31/2017 | N/A | -12 | -5 | -5 | N/A |
9/30/2017 | N/A | -11 | -4 | -4 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: 2Q3A is forecast to remain unprofitable over the next 3 years.
수익 vs 시장: 2Q3A is forecast to remain unprofitable over the next 3 years.
고성장 수익: 2Q3A is forecast to remain unprofitable over the next 3 years.
수익 대 시장: 2Q3A's revenue (56.6% per year) is forecast to grow faster than the German market (3.3% per year).
고성장 수익: 2Q3A's revenue (56.6% per year) is forecast to grow faster than 20% per year.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: Insufficient data to determine if 2Q3A's Return on Equity is forecast to be high in 3 years time